Given the complexity of SCD in the Kcne2‐/‐ mouse model and potential parallels to human SCD (KCNE2‐associated and otherwise), we sought to investigate potential treatment approaches focused on reducing the incidence of ischemia‐initiated ventricular arrhythmias. This evidence concerns the gene KCNE2 and Ventricular arrhythmia.